DOwnload For Immediate Release Vancouver, British Columbia, November 28, 2024– Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage...
DOWNLOAD The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the Offering. For Immediate Release Vancouver, British Columbia, November 27, 2024 – Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or...
DOWNLOAD November 25, 2024, Vancouver, British Columbia – Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response targeting technologies,...
Download November 20, 2024, Vancouver, British Columbia – Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response targeting technologies, is...
Be in the know with the Rakovina Therapeutics monthly investor newsletter! Each month you’ll find out what’s going on with the company and be the first to receive news release straight to your inbox.
Recent Comments